Hipertension y Riesgo Vascular最新文献

[Peculiarities in the management of arterial hypertension in the elderly: Consensus document of the Central American and Caribbean Society of arterial hypertension]. [老年人动脉高血压管理的特殊性：中美洲和加勒比动脉高血压学会共识文件]。

IF 1.2

Hipertension y Riesgo Vascular Pub Date : 2024-11-04 DOI: 10.1016/j.hipert.2024.09.004

C Sepulveda Gallardo, A I Barrientos, M H Koretzky, F Wyss, O Valdez Tiburcio, N Báez Noyer, E Sanchez, A Gonzalez, W Dones, P López Contreras, M Camafort

{"title":"[Peculiarities in the management of arterial hypertension in the elderly: Consensus document of the Central American and Caribbean Society of arterial hypertension].","authors":"C Sepulveda Gallardo, A I Barrientos, M H Koretzky, F Wyss, O Valdez Tiburcio, N Báez Noyer, E Sanchez, A Gonzalez, W Dones, P López Contreras, M Camafort","doi":"10.1016/j.hipert.2024.09.004","DOIUrl":"https://doi.org/10.1016/j.hipert.2024.09.004","url":null,"abstract":"Arterial hypertension is one of the most prevalent diseases in the field of geriatrics and is also a risk factor for pathologies that frequently result in hospital admissions, such as heart failure and stroke. This article addresses both pharmacological and non-pharmacological diagnosis and treatment strategies, focusing on the role of frailty as a guiding principle in determining the most appropriate course of treatment, emphasizing patient-centred prescribing. Furthermore, the article reviews other frequent topics, such as polypharmacy and orthostatic hypotension. Moreover, a concise overview of the current evidence in geriatrics on ambulatory blood pressure monitoring and self-measurement of blood pressure will be provided. Furthermore, a brief summary of the underlying pathophysiology and current epidemiological trends is provided. This consensus is founded upon the initial premise that a comprehensive geriatric assessment should be conducted to ascertain whether a blood pressure reduction strategy could confer a net benefit for elderly patients while simultaneously avoiding an increase in the safety risks associated with these strategies and preventing a de-prescription due to ageism. This is particularly important given the significance of maintaining optimal blood pressure control to prevent related complications.","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142584282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Update on the diagnosis of the pheochromocytoma. 嗜铬细胞瘤诊断的最新进展。

IF 1.2

Hipertension y Riesgo Vascular Pub Date : 2024-10-10 DOI: 10.1016/j.hipert.2024.08.001

E Achote, O F Arroyo Ripoll, M Araujo-Castro

引用次数: 0

[Arterial stiffness detection in women with recent history of pre-eclampsia]. [近期有先兆子痫病史的妇女的动脉僵化检测]。

IF 1.2

Hipertension y Riesgo Vascular Pub Date : 2024-10-09 DOI: 10.1016/j.hipert.2024.07.007

A M Ghelfi, M N Lassus, F A Passarino, R F Mamprin D'Andrea, L N Fierro, L L Velez, E A Hails, M A Paciocco, J G Kilstein, J O Galíndez

{"title":"[Arterial stiffness detection in women with recent history of pre-eclampsia].","authors":"A M Ghelfi, M N Lassus, F A Passarino, R F Mamprin D'Andrea, L N Fierro, L L Velez, E A Hails, M A Paciocco, J G Kilstein, J O Galíndez","doi":"10.1016/j.hipert.2024.07.007","DOIUrl":"https://doi.org/10.1016/j.hipert.2024.07.007","url":null,"abstract":"Introduction: Preeclampsia (PE) is a complication of hypertensive disorders of pregnancy, whose pathophysiology involves endothelial dysfunction. Early establishment of subclinical vascular lesions such as arterial stiffness (AS) could explain the development of cardiovascular disease later in life. AS can be assessed non-invasively using carotid-femoral pulse wave velocity (cf-PWV), aortic systolic blood pressure (ao-SBP) and augmentation index (IAx). We aim to determine cf-PWV, ao-SBP and AIx in women who recently underwent PE and compare it with a control group.Materials and methods: Cross-sectional study, carried out from 2022 to 2023 in Argentina. Group 1: women who developed PE.Exclusion criteria: history of chronic hypertension, diabetes, autoimmune disease, chronic kidney disease, cardiovascular disease, PE in previous pregnancies; treatment with calcium antagonists during pregnancy; treatment with calcium antagonists, angiotensin-converting enzyme inhibitors or diuretics in the postpartum period. Group 2: healthy postpartum periods. PWV-cf, ao-SBP and IAx were measured in the first 72hours postpartum using Aortic.Results: Seventy-onewomen were included: Group 1 (n=30); Group 2 (n=41). Group 1 presented higher PWV-cf=6.70±0.68 vs. 5.41±0.48 m/s (P<.0001); ao-SBP=118.3±9.6 vs. 101.2±9.8mmHg (P<.0001); and IAu=22.7±10.7 vs. 9.3±11.9% (P<.0001). In Group 1 there were 25 of 30 women who presented AS parameters (OR=8.50; 95% CI=3.32-15.29; P<.0001).Conclusion: Patients with a recent history of PE showed higher cf-PWV, ao-SBP and AIx values, compatible with AS.","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142401574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Design and rationale: Observational Study of the Argentine Group for the Study of Lipoprotein (a)]. [设计与原理：阿根廷脂蛋白（a）研究小组的观察性研究]。

IF 1.2

Hipertension y Riesgo Vascular Pub Date : 2024-10-08 DOI: 10.1016/j.hipert.2024.07.005

P Corral, A Lavalle Cobo, M F Arrupe, L Schreier, G Matta, N F Renna

{"title":"[Design and rationale: Observational Study of the Argentine Group for the Study of Lipoprotein (a)].","authors":"P Corral, A Lavalle Cobo, M F Arrupe, L Schreier, G Matta, N F Renna","doi":"10.1016/j.hipert.2024.07.005","DOIUrl":"https://doi.org/10.1016/j.hipert.2024.07.005","url":null,"abstract":"Introduction: Elevated levels of Lipoprotein(a) [Lp(a)] have been linked to increased cardiovascular risk globally. However, comprehensive studies on Lp(a) levels and their impact on cardiovascular health in Argentina are lacking. The Argentine Group for the Study of Lipoprotein (a) [GAELp(a)] aims to address this gap through an observational study designed to evaluate the prevalence and consequences of elevated Lp(a) levels in the Argentine population.Methods: The GAELp(a) study will recruit participants from diverse regions across Argentina. Eligible individuals will undergo comprehensive assessments, including demographic data collection, medical history review, and laboratory analyses to measure Lp(a) levels. The study will employ rigorous statistical analyses to explore the association between elevated Lp(a) levels and cardiovascular outcomes, considering potential confounding variables.Results: Anticipated outcomes of the GAELp(a) study include a detailed characterization of Lp(a) levels within the Argentine population and their correlation with cardiovascular diseases. By elucidating these relationships, the study aims to provide valuable insights into the prevalence and impact of elevated Lp(a) on cardiovascular health in Argentina.Conclusion: The GAELp(a) observational study holds promise for enhancing our understanding of Lp(a)-related cardiovascular risk in Argentina. Findings from this study may contribute to the development of targeted interventions, clinical guidelines, and public health policies aimed at reducing cardiovascular morbidity and mortality associated with elevated Lp(a) levels. Through collaborative efforts, the GAELp(a) study seeks to advance cardiovascular research and improve healthcare outcomes in Argentina.","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142394074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Metastatic pheochromocytoma: An unusual case and its multidisciplinary management. 转移性嗜铬细胞瘤：一个不寻常的病例及其多学科治疗。

IF 1.2

Hipertension y Riesgo Vascular Pub Date : 2024-09-28 DOI: 10.1016/j.hipert.2024.09.002

J M Ruiz-Cánovas, E A Achote-Rea, T Alonso-Gordoa, A Martínez-Lorca, M Araujo-Castro

引用次数: 0

[De Novo Hypertensive Disorders in the Postpartum Period: Considerations on Diagnosis, Risk Factors, and Potential Intervention Strategies]. [产后新发高血压疾病：关于诊断、风险因素和潜在干预策略的考虑]。

IF 1.2

Hipertension y Riesgo Vascular Pub Date : 2024-09-25 DOI: 10.1016/j.hipert.2024.09.001

P G Irusta

引用次数: 0

[High blood pressure and depression, an underestimated comorbidity]. [高血压和抑郁症，一种被低估的并发症]。

IF 1.2

Hipertension y Riesgo Vascular Pub Date : 2024-08-13 DOI: 10.1016/j.hipert.2024.07.004

Q Foguet-Boreu, L Ayerbe García-Morzón

引用次数: 0

Six weeks of a concurrent training therapy improves endothelial function and arterial stiffness in hypertensive adults with minimum non-responders. 为期六周的同步训练疗法可改善最低限度无应答的成人高血压患者的内皮功能和动脉僵化。

IF 1.2

Hipertension y Riesgo Vascular Pub Date : 2024-07-29 DOI: 10.1016/j.hipert.2024.07.001

C Alvarez, L Peñailillo, P Ibacache-Saavedra, D Jerez-Mayorga, C Campos-Jara, D C Andrade, G V Guimarães, E Gomes-Ciolac, P Delgado-Floody, M Izquierdo, A N Gurovich

{"title":"Six weeks of a concurrent training therapy improves endothelial function and arterial stiffness in hypertensive adults with minimum non-responders.","authors":"C Alvarez, L Peñailillo, P Ibacache-Saavedra, D Jerez-Mayorga, C Campos-Jara, D C Andrade, G V Guimarães, E Gomes-Ciolac, P Delgado-Floody, M Izquierdo, A N Gurovich","doi":"10.1016/j.hipert.2024.07.001","DOIUrl":"https://doi.org/10.1016/j.hipert.2024.07.001","url":null,"abstract":"Background: This study aimed to examine the effects of a six-week of concurrent training using high-intensity interval plus resistance training on flow-mediated dilation and pulse wave velocity in hypertensive, elevated blood pressure, or normotensive. A secondary goal was to analyze the inter-individual variability.Methods: A randomized controlled clinical trial was executed with 60 adult participants distributed across six groups: three control groups of hypertensive, elevated blood pressure, or normotensive and other three experimental hypertensive, elevated blood pressure, and normotensive groups, each comprising n=10 individuals. Participants underwent a six-week intervention of concurrent exercise using high-intensity interval plus resistance training three-weekly. Flow mediated dilation and pulse wave velocity and secondary vascular assessments were conducted before and after the intervention.Results: The hypertensive exercise group exhibited a significant increase in flow mediated dilation (Δ+7.7%; p=0.003) and a reduction in pulse wave velocity (Δ-1.2ms-1; p<0.0001). The normotensive exercise group also showed a significant increase in flow mediated dilation (Δ+8.4%, p=0.002).Conclusion: The six-week concurrent exercise using high-intensity interval plus resistance training protocol, characterized by its clinical time-efficiency, was effective in improving endothelial function, as demonstrated by increased flow mediated dilation, and in reducing arterial stiffness, indicated by decreased pulse wave velocity.","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141856722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Inter-arm blood pressure difference: Consecutive versus simultaneous measurements in treated and controlled hypertense patients]. [臂间血压差：治疗和控制高血压患者的连续测量与同步测量]。

IF 1.2

Hipertension y Riesgo Vascular Pub Date : 2024-07-22 DOI: 10.1016/j.hipert.2024.06.005

A Delucchi, D Fernández, M Sorini, P Reisin, M Scarabino, P Rodríguez

{"title":"[Inter-arm blood pressure difference: Consecutive versus simultaneous measurements in treated and controlled hypertense patients].","authors":"A Delucchi, D Fernández, M Sorini, P Reisin, M Scarabino, P Rodríguez","doi":"10.1016/j.hipert.2024.06.005","DOIUrl":"https://doi.org/10.1016/j.hipert.2024.06.005","url":null,"abstract":"The inter-arm difference (IAD) of systolic blood pressure (SBP) is associated with higher cardiovascular risk. We compared simultaneous and consecutive recordings in measuring IAD of SBP, and evaluated reproducibility between visits. 143 hypertensive patients (63.8±9.5 years, 51.7% women) treated and controlled with stable antihypertensive medication for a period of ≥3 months were included. Blood pressure (BP) in both arms was measured simultaneously and consecutively with an automatic oscillometric device, in two visits. The IAD of the simultaneous SBP was significantly lower compared to the consecutive one, both in the first (3.51±4.1 vs. 4.40±3.7mmHg; P<.01) and in the second visit (3.62±3.5 vs. 5.69±5.1mmHg; P<.001). When the IAD of SBP was categorized as ≥10 or <10mmHg, the reproducibility between visits was insignificant in both simultaneous measurements and consecutive measurements. The frequency of initial dominance was similar between the left and right arm in simultaneous ones (46.2 vs. 43.3%), and greater in the right arm in consecutive ones (55.2 vs. 38.5). The persistence of dominance between both visits was significantly higher when SBP was measured simultaneously (54.4% vs. 45.5%; P<.01). Our study shows that to define the arm with the highest BP, simultaneous measurements are preferable. In treated and controlled hypertensive patients, the poor persistence of initial dominance between visits requires us to review the recommendation of recording, during follow-up, the BP in the arm where it was highest on the first visit.","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141752973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Antihypertensive prescription in type 2 diabetes patients in Andalusia and SEH-LELHA 2022 guidelines: An economic cost evaluation]. [安达卢西亚 2 型糖尿病患者的抗高血压处方与 SEH-LELHA 2022 准则：经济成本评估]。

IF 1.2

Hipertension y Riesgo Vascular Pub Date : 2024-07-10 DOI: 10.1016/j.hipert.2024.06.004

D Martín-Enguix, J C Aguirre Rodríguez, M Guisasola Cárdenas, M N Generoso Torres, A Hidalgo Rodríguez, M Sánchez Cambronero, A González Bravo

{"title":"[Antihypertensive prescription in type 2 diabetes patients in Andalusia and SEH-LELHA 2022 guidelines: An economic cost evaluation].","authors":"D Martín-Enguix, J C Aguirre Rodríguez, M Guisasola Cárdenas, M N Generoso Torres, A Hidalgo Rodríguez, M Sánchez Cambronero, A González Bravo","doi":"10.1016/j.hipert.2024.06.004","DOIUrl":"https://doi.org/10.1016/j.hipert.2024.06.004","url":null,"abstract":"Objective: This study aims to analyze the prescription of antihypertensive drugs in patients with type 2 diabetes (T2D) in Andalusia, comparing it with the SEH-LELHA 2022 guidelines, and to assess the direct cost of these treatments.Materials and methods: A multicentric, cross-sectional, and descriptive study was conducted with 385 T2D patients. Participants were randomly selected from the patient lists of 120 primary care physicians from Andalusia. Inclusion criteria included a diagnosis of T2D and complete clinical records for the year 2022. Demographic data and drug prescription information were collected, with the average cost per patient being calculated.Results: The mean age of the subjects was 70.72 years, with 53.51% being male. A total of 70.9% of the patients were taking antihypertensive drugs, the most common being ACE inhibitors/ARBs (70.9%), diuretics (70.1%), beta-blockers (40.0%), and calcium channel blockers (20.0%). Each patient took an average of 2.46±1.06 antihypertendsive, and fixed association of 2 or more antihypertensive drugs were used by 40.9% of the studied patients. The annual cost per patient was 141.45€/year.Conclusions: The study reveals strong adherence to the SEH-LELHA 2022 guidelines among physicians in Andalusia regarding the of antihypertensives for T2D patients, with a significant preference for Renin-Angiotensin System blockers, diuretics, and beta-blockers. However, a notable deviation in prescription practices was observed with the frequent choice of doxazosin over spironolactone, despite the latter being the recommended option for resistant hypertension. Although the overall expenditure on antihypertensives is moderate, their cost-effectiveness is enhanced by the efficacy of these treatments in preventing cardiovascular complications.","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":null,"pages":null},"PeriodicalIF":1.2,"publicationDate":"2024-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141591630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0